Protein and mRNA levels of SIRT2 in five human glioma cell lines (T98G, U87MG, U251, A172, and CCF-STTG1) were also lower than two normal human astrocyte cell lines (NHA and HA) (70). This evidence concerns the gene SIRT2 and central nervous system cancer.